150 related articles for article (PubMed ID: 15306537)
41. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens.
Sperlágh B; Windisch K; Andó RD; Sylvester Vizi E
Neurochem Int; 2009 Jun; 54(7):452-7. PubMed ID: 19428788
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
Gessa GL; Mascia MS; Casu MA; Carta G
Eur J Pharmacol; 1997 May; 327(1):R1-2. PubMed ID: 9185841
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.
Patel HJ; Birrell MA; Crispino N; Hele DJ; Venkatesan P; Barnes PJ; Yacoub MH; Belvisi MG
Br J Pharmacol; 2003 Sep; 140(2):261-8. PubMed ID: 12970104
[TBL] [Abstract][Full Text] [Related]
44. Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.
Ding Z; Cowan A; Rawls SM
Brain Res; 2005 Dec; 1065(1-2):147-51. PubMed ID: 16309633
[TBL] [Abstract][Full Text] [Related]
45. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
Rawls SM; Cabassa J; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
[TBL] [Abstract][Full Text] [Related]
46. Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.
Izzo AA; Mascolo N; Tonini M; Capasso F
Br J Pharmacol; 2000 Mar; 129(5):984-90. PubMed ID: 10696099
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon.
Storr M; Sibaev A; Marsicano G; Lutz B; Schusdziarra V; Timmermans JP; Allescher HD
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G110-7. PubMed ID: 12893627
[TBL] [Abstract][Full Text] [Related]
48. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
Pertwee RG; Griffin G; Lainton JA; Huffman JW
Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005
[TBL] [Abstract][Full Text] [Related]
49. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
50. Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.
Guagnini F; Cogliati P; Mukenge S; Ferla G; Croci T
Br J Pharmacol; 2006 Aug; 148(8):1165-73. PubMed ID: 16783406
[TBL] [Abstract][Full Text] [Related]
51. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
Coruzzi G; Adami M; Coppelli G; Frati P; Soldani G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):715-8. PubMed ID: 10619190
[TBL] [Abstract][Full Text] [Related]
52. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
Meschler JP; Kraichely DM; Wilken GH; Howlett AC
Biochem Pharmacol; 2000 Nov; 60(9):1315-23. PubMed ID: 11008125
[TBL] [Abstract][Full Text] [Related]
53. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
54. Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors.
Izzo AA; Mascolo N; Borrelli F; Capasso F
Br J Pharmacol; 1998 Aug; 124(7):1363-8. PubMed ID: 9723946
[TBL] [Abstract][Full Text] [Related]
55. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
Kathmann M; Bauer U; Schlicker E; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
[TBL] [Abstract][Full Text] [Related]
56. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus.
Schlicker E; Timm J; Zentner J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):583-9. PubMed ID: 9402037
[TBL] [Abstract][Full Text] [Related]
57. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
58. Involvement of the cannabinoid CB1 receptor in the opioid inhibition of the response to cholecystokinin and acute withdrawal response.
Romanelli L; Palmery M; Tucci P; Amico MC; Morrone LA; Valeri P
Neurotoxicology; 2005 Oct; 26(5):819-27. PubMed ID: 15913779
[TBL] [Abstract][Full Text] [Related]
59. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
[TBL] [Abstract][Full Text] [Related]
60. Antitussive effect of WIN 55212-2, a cannabinoid receptor agonist.
Morita K; Kamei J
Eur J Pharmacol; 2003 Aug; 474(2-3):269-72. PubMed ID: 12921873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]